These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 23943543)

  • 21. Microemulsion and poloxamer microemulsion-based gel for sustained transdermal delivery of diclofenac epolamine using in-skin drug depot: in vitro/in vivo evaluation.
    Fouad SA; Basalious EB; El-Nabarawi MA; Tayel SA
    Int J Pharm; 2013 Sep; 453(2):569-78. PubMed ID: 23792042
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sustained Anti-inflammatory Effect of Resveratrol-Phospholipid Complex Embedded Polymeric Patch.
    Kalita B; Das MK; Sarma M; Deka A
    AAPS PharmSciTech; 2017 Apr; 18(3):629-645. PubMed ID: 27173988
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transdermal delivery of naltrexol and skin permeability lifetime after microneedle treatment in hairless guinea pigs.
    Banks SL; Pinninti RR; Gill HS; Paudel KS; Crooks PA; Brogden NK; Prausnitz MR; Stinchcomb AL
    J Pharm Sci; 2010 Jul; 99(7):3072-80. PubMed ID: 20166200
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A duplex "Gemini" prodrug of naltrexone for transdermal delivery.
    Hammell DC; Hamad M; Vaddi HK; Crooks PA; Stinchcomb AL
    J Control Release; 2004 Jun; 97(2):283-90. PubMed ID: 15196755
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhancement of skin permeation of docetaxel: a novel approach combining microneedle and elastic liposomes.
    Qiu Y; Gao Y; Hu K; Li F
    J Control Release; 2008 Jul; 129(2):144-50. PubMed ID: 18538885
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optimizing microneedle arrays to increase skin permeability for transdermal drug delivery.
    Al-Qallaf B; Das DB
    Ann N Y Acad Sci; 2009 Apr; 1161():83-94. PubMed ID: 19426308
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Using laser microporation to improve transdermal delivery of diclofenac: Increasing bioavailability and the range of therapeutic applications.
    Bachhav YG; Heinrich A; Kalia YN
    Eur J Pharm Biopharm; 2011 Aug; 78(3):408-14. PubMed ID: 21397689
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transdermal delivery of relatively high molecular weight drugs using novel self-dissolving microneedle arrays fabricated from hyaluronic acid and their characteristics and safety after application to the skin.
    Liu S; Jin MN; Quan YS; Kamiyama F; Kusamori K; Katsumi H; Sakane T; Yamamoto A
    Eur J Pharm Biopharm; 2014 Feb; 86(2):267-76. PubMed ID: 24120887
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ethosomal Hydrogel of Raloxifene HCl: Statistical Optimization & Ex Vivo Permeability Evaluation Across Microporated Pig Ear Skin.
    Thakkar HP; Savsani H; Kumar P
    Curr Drug Deliv; 2016; 13(7):1111-1122. PubMed ID: 26787414
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of diclofenac prodrugs for enhancing transdermal delivery.
    Lobo S; Li H; Farhan N; Yan G
    Drug Dev Ind Pharm; 2014 Mar; 40(3):425-32. PubMed ID: 24517636
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel solid-in-oil nanosuspension for transdermal delivery of diclofenac sodium.
    Piao H; Kamiya N; Hirata A; Fujii T; Goto M
    Pharm Res; 2008 Apr; 25(4):896-901. PubMed ID: 17896098
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vivo evaluation of a transdermal codrug of 6-beta-naltrexol linked to hydroxybupropion in hairless guinea pigs.
    Kiptoo PK; Paudel KS; Hammell DC; Hamad MO; Crooks PA; Stinchcomb AL
    Eur J Pharm Sci; 2008 Apr; 33(4-5):371-9. PubMed ID: 18321686
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of liposomal drug formulations for transdermal iontophoretic drug delivery.
    Malinovskaja-Gomez K; Espuelas S; Garrido MJ; Hirvonen J; Laaksonen T
    Eur J Pharm Sci; 2017 Aug; 106():294-301. PubMed ID: 28625748
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-Ablative Fractional Laser to Facilitate Transdermal Delivery.
    Ganti SS; Banga AK
    J Pharm Sci; 2016 Nov; 105(11):3324-3332. PubMed ID: 27624669
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Versatility of hydrogel-forming microneedles in in vitro transdermal delivery of tuberculosis drugs.
    Anjani QK; Permana AD; Cárcamo-Martínez Á; Domínguez-Robles J; Tekko IA; Larrañeta E; Vora LK; Ramadon D; Donnelly RF
    Eur J Pharm Biopharm; 2021 Jan; 158():294-312. PubMed ID: 33309844
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Microneedle-assisted delivery of verapamil hydrochloride and amlodipine besylate.
    Kaur M; Ita KB; Popova IE; Parikh SJ; Bair DA
    Eur J Pharm Biopharm; 2014 Feb; 86(2):284-91. PubMed ID: 24176676
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Controlled release of diclofenac sodium in glycolipid incorporated micro emulsions.
    Premarathne EP; Karunaratne DN; Perera AD
    Int J Pharm; 2016 Sep; 511(2):890-8. PubMed ID: 27477103
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current aspects of formulation efforts and pore lifetime related to microneedle treatment of skin.
    Milewski M; Brogden NK; Stinchcomb AL
    Expert Opin Drug Deliv; 2010 May; 7(5):617-29. PubMed ID: 20205604
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of terpene concentrations on the skin penetration of diclofenac sodium.
    Nokhodchi A; Sharabiani K; Rashidi MR; Ghafourian T
    Int J Pharm; 2007 Apr; 335(1-2):97-105. PubMed ID: 17174049
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mathematical modelling of microneedle-mediated transdermal delivery of drug nanocarriers into skin tissue and circulatory system.
    Newell B; Zhan W
    J Control Release; 2023 Aug; 360():447-467. PubMed ID: 37429359
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.